Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19
Clinical trial NCT06960928 · RECRUITING
Trial details
- NCT number
- NCT06960928
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-18
- Primary completion
- 2026-12-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.